Ben-Horin, S., Ungar, B., & Roblin, X. (2017). Letter: Can addition of an immunomodulator really reverse antibody formation and loss of response in patients treated with adalimumab? Authors' reply. Alimentary Pharmacology & Therapeutics, 45(5), 760. https://doi.org/10.1111/apt.13932
Chicago Style (17th ed.) CitationBen-Horin, S., B. Ungar, and X. Roblin. "Letter: Can Addition of an Immunomodulator Really Reverse Antibody Formation and Loss of Response in Patients Treated with Adalimumab? Authors' Reply." Alimentary Pharmacology & Therapeutics 45, no. 5 (2017): 760. https://doi.org/10.1111/apt.13932.
MLA (9th ed.) CitationBen-Horin, S., et al. "Letter: Can Addition of an Immunomodulator Really Reverse Antibody Formation and Loss of Response in Patients Treated with Adalimumab? Authors' Reply." Alimentary Pharmacology & Therapeutics, vol. 45, no. 5, 2017, p. 760, https://doi.org/10.1111/apt.13932.